OptimizeRx (Nasdaq: OPRX), a leading provider of healthcare technology solutions for life sciences companies, has confirmed receiving a notice of nominations from stockholder Whetstone Capital Advisors, . The notice indicates Whetstone's intention to nominate two candidates for election to the OptimizeRx Board of Directors at the company's 2025 Annual Meeting of Stockholders.
The OptimizeRx Board will review the nominations and provide their formal recommendation in the upcoming definitive proxy statement, which will be filed with the SEC and distributed to eligible voting stockholders. The company emphasized that no stockholder action is currently required, and the 2025 Annual Meeting date has not yet been scheduled.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.